AccessibilityHelpAbout Us
Futura Medical Plc logo

Futura Medical Plc(LSE) FUM

Market Cap£1.39MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2003)-100%
5 Year-99%
1 Year-97%
1 Month-48%
£0.00
+4.17%
+0.00Today
Futura Medical Plc last closing stock price
MetricPriceDate
Last closeGBX 0.252026-09-11
Futura Medical Plc stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-10.43%GBX 0.282026-09-04
1 month-48.45%GBX 0.482026-08-12
3 month-57.07%GBX 0.582026-06-12
Year to date-77.77%GBX 1.122025-12-31
1 year-97.22%GBX 8.952025-09-11
3 year-99.53%GBX 53.002023-09-12
5 year-99.38%GBX 40.002021-09-10
Since inception-99.66%GBX 0.712003-07-22

Futura Medical Plc Financials at a Glance

Market Cap

£1.39MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

£10.24M

Net Income (TTM)

-£9.96M

EPS (TTM)

-£0.01

P/E Ratio

-0.29

Dividend

£0.00

Beta (Volatility)

-0.12 (Low)

Price

£0.00

Volume

3,697,603

Open

£0.00

Previous Close

£0.00

Daily Range

£0.00 - £0.00

52-Week Range

£0.00 - £0.10

Estimated Earnings Date

Apr 14, 2027

FUM News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Futura Medical Plc

Futura Medical plc is a pharmaceutical company focused on developing innovative consumer healthcare products, particularly in the sexual health and pain management sectors. The company is known for its flagship product, MED3000, a topical gel designed to treat erectile dysfunction.

Products and Services
  • MED3000: Topical gel for erectile dysfunction
  • TPR100: Topical diclofenac gel for pain relief
  • CBD100: Cannabidiol-based topical application
Growth Outlook
  • Recent product innovations position the company for market expansion
  • Strong demand in sexual health and pain management sectors
  • Strategic partnerships may enhance distribution capabilities
Financial Highlights
  • Q2 2026 revenue of £1.62 million, showing growth potential
  • Cash and cash equivalents of £1.24 million as of June 2026
  • Trailing twelve months (TTM) gross profit margin of 1.11%
Futura Medical plc operates in a competitive biotechnology industry, focusing on unmet medical needs. The company’s innovative products, particularly in sexual health, cater to a growing market. The recent revenue growth indicates a positive trajectory, while the cash position supports ongoing research and development efforts. The strategic focus on partnerships and product innovation may further enhance market presence and financial performance. Investors may find Futura Medical plc an intriguing opportunity within the healthcare sector.
AI Generated • Sep 3, 2026

Industry

Pharmaceuticals

Sector

Health Care

CEO

Alexander James Hanbury Duggan

Website

www.futuramedical.com

Headquarters

Guildford, SU GU2 7YG, GB

FUM Financials

Key Financial Metrics (TTM)

Gross Margin

110.59%

Operating Margin

-9.93%

Net Income Margin

-158.21%

Return on Equity

-152.42%

Return on Capital

-201.70%

Return on Assets

-88.30%

Earnings Yield

-3.45%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

£1.39MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

581.33M

Volume

3.70M

Avg. Volume

6.64M

Financials (TTM)

Gross Profit

£7.61M

Operating Income

-£6.66M

EBITDA

-£6.29M

Operating Cash Flow

-£4.29M

Capital Expenditure

-£903.73K

Free Cash Flow

-£5.20M

Cash & ST Invst.

£1.24M

Total Debt

£0.00

Futura Medical Plc Performance Analysis

Futura Medical Plc annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31GBP 0N/A
20232023-12-31GBP 3,100,968N/A
20242024-12-31GBP 13,926,122349.1%
20252025-12-31GBP 1,696,660-87.8%
Futura Medical Plc sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-12-31-1.1%
Q22025-06-30-85.5%
Q42025-12-31-30.5%
Q22026-06-30133.1%
Futura Medical Plc annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31GBP -0.0210.9%
20232023-12-31GBP -0.028.9%
20242024-12-31GBP 0.00N/A
20252025-12-31GBP -0.03N/A
Futura Medical Plc sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-12-31-68.8%
Q22025-06-30-2270.0%
Q42025-12-3180.2%
Q22026-06-3053.5%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

£1.62M

-76.8%

Gross Profit

£1.57M

-67.1%

Gross Margin

96.54%

N/A

Market Cap

£1.39MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

£99.24K

N/A

Employees

14

N/A

Net Income

-£1.18M

-217.9%

EBITDA

-£1.24M

-234.0%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

£1.24M

-68.3%

Total Debt

£0.00

N/A

Accounts Receivable

£2.21M

+6.1%

Inventory

£79.00

-43.6%

Long Term Debt

£0.00

N/A

Short Term Debt

£0.00

N/A

Return on Assets

-88.30%

N/A

Return on Invested Capital

-10.23%

N/A

Free Cash Flow

-£2.16M

+43.6%

Operating Cash Flow

-£2.16M

+28.2%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
OBD.LOxford BioDynamics Plc
£0.00+0.00%
AGL.LCelLBxHealth plc
£0.01-5.64%
TCF.LTheracryf Plc
£0.00+0.00%
NFX.LNuformix plc
£0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
TNONTenon Medical
$5.95+0.12%
ACVAACV Auctions
$10.44+0.45%
ETHAiShares Ethereum Trust - iShares Ethereum Trust ETF
$19.17+0.03%
BITOProShares Trust - ProShares Bitcoin ETF
$10.35-0.00%

Questions About FUM

What is the current price of Futura Medical Plc?

Futura Medical Plc is trading at £0.00 per share.

What is the 52-week range for Futura Medical Plc?

Over the past 52 weeks, Futura Medical Plc has traded between £0.00 and £0.10.

How much debt does Futura Medical Plc have?

As of the most recent reporting period, Futura Medical Plc reported total debt of £0.00.

How much cash does Futura Medical Plc have on hand?

Futura Medical Plc reported £3.40M in cash and cash equivalents in its most recent financial results.

What is Futura Medical Plc’s dividend yield?

Futura Medical Plc does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services